TY - JOUR
T1 - Y-shaped bis-arylethenesulfonic acid esters
T2 - Potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors
AU - Yang, Fengzhi
AU - Xie, Fangzhou
AU - Zhang, Ying
AU - Xia, Yu
AU - Liu, Wenlu
AU - Jiang, Faqin
AU - Lam, Celine
AU - Qiao, Yixue
AU - Xie, Dongsheng
AU - Li, Jianqi
AU - Fu, Lei
N1 - Publisher Copyright:
© 2017
PY - 2017
Y1 - 2017
N2 - Known PTP1B inhibitors with bis-anionic moieties exhibit potent inhibitory activity, good selectivity, however, they are incapable of penetrating cellular membranes. Based upon our finding of a new pharmacophoric group in inhibition of PTP1B and the structural characteristics of the binding pocket of PTP1B, a series of bis-arylethenesulfonic acid ester derivatives were designed and synthesized. These novel molecules, particularly Y-shaped bis-arylethenesulfonic acid ester derivatives, exhibited high PTP1B inhibitory activity, moderate selectivity, and great potential in penetrating cellular membranes (compound 7p, CLog P = 9.73, Papp = 9.6 × 10-6 cm/s; IC50 = 140, 1290 and 920 nM on PTP1B, TCPTP and SHP2, respectively). Docking simulations suggested that these Y-shaped inhibitors might interact with multiple secondary binding sites in addition to the catalytic site of PTP1B.
AB - Known PTP1B inhibitors with bis-anionic moieties exhibit potent inhibitory activity, good selectivity, however, they are incapable of penetrating cellular membranes. Based upon our finding of a new pharmacophoric group in inhibition of PTP1B and the structural characteristics of the binding pocket of PTP1B, a series of bis-arylethenesulfonic acid ester derivatives were designed and synthesized. These novel molecules, particularly Y-shaped bis-arylethenesulfonic acid ester derivatives, exhibited high PTP1B inhibitory activity, moderate selectivity, and great potential in penetrating cellular membranes (compound 7p, CLog P = 9.73, Papp = 9.6 × 10-6 cm/s; IC50 = 140, 1290 and 920 nM on PTP1B, TCPTP and SHP2, respectively). Docking simulations suggested that these Y-shaped inhibitors might interact with multiple secondary binding sites in addition to the catalytic site of PTP1B.
KW - Arylethenesulfonic acid esters
KW - PTP1B inhibitors
KW - Phosphotyrosine mimics
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85016395391&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2017.03.060
DO - 10.1016/j.bmcl.2017.03.060
M3 - Article
C2 - 28372909
AN - SCOPUS:85016395391
SN - 0960-894X
VL - 27
SP - 2166
EP - 2170
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 10
ER -